components_HeaderAdBanner_2

components_HeaderAdBanner_3
components_StockPageHeaderMobile__0
components_StockPageHeaderMobile__1

Neurobiological Technologies

NTII
US64124W3043
A0M1WB

components_StockPageHeaderMobile__3

0,00
components_StockPageHeader__1
+0
components_StockPageHeader__2
+0 %
P

components_charts_RevenueChart_0

components_charts_RevenueChart_13

Neurobiological Technologies components_charts_RevenueChart_15

components_charts_RevenueChart_14Neurobiological Technologies components_charts_RevenueChart_8Neurobiological Technologies components_charts_RevenueChart_10Neurobiological Technologies components_charts_RevenueChart_9
2010e15,89 number_format_mio undefined0 undefined−48,50 number_format_mio undefined
200926,35 number_format_mio undefined3,68 number_format_mio undefined3,12 number_format_mio undefined
200814,76 number_format_mio undefined−16,70 number_format_mio undefined−16,32 number_format_mio undefined
200717,67 number_format_mio undefined−15,60 number_format_mio undefined−14,13 number_format_mio undefined
200612,34 number_format_mio undefined−16,44 number_format_mio undefined−27,84 number_format_mio undefined
20053,10 number_format_mio undefined−12,58 number_format_mio undefined−24,98 number_format_mio undefined
20042,79 number_format_mio undefined−2,41 number_format_mio undefined−1,81 number_format_mio undefined
20031,98 number_format_mio undefined−2,83 number_format_mio undefined−2,69 number_format_mio undefined
20020 undefined−4,65 number_format_mio undefined−4,27 number_format_mio undefined
20014,78 number_format_mio undefined1,03 number_format_mio undefined1,59 number_format_mio undefined
20000 undefined−3,28 number_format_mio undefined−3,12 number_format_mio undefined
1999100 000,00 undefined−3,74 number_format_mio undefined−3,69 number_format_mio undefined
19982,10 number_format_mio undefined−2,27 number_format_mio undefined−2,17 number_format_mio undefined
19970 undefined−7,78 number_format_mio undefined−7,37 number_format_mio undefined
19960 undefined−5,72 number_format_mio undefined−5,21 number_format_mio undefined
1995680 000,00 undefined−5,28 number_format_mio undefined−5,28 number_format_mio undefined
19940 undefined−3,91 number_format_mio undefined−3,67 number_format_mio undefined
19930 undefined−2,75 number_format_mio undefined−2,61 number_format_mio undefined
19920 undefined−1,18 number_format_mio undefined−1,13 number_format_mio undefined
19910 undefined−630 000,00 undefined−590 000,00 undefined
19900 undefined−270 000,00 undefined−260 000,00 undefined

Neurobiological Technologies components_StockTable__14

  • components_StockTable_20

  • components_StockTable_21

  • components_StockTable_17

  • components_StockTable_18

  • components_StockTable_19

components_StockTable__16
components_StockDataTable_BalanceSheet_49

components_PaywallOverlay_0

components_PaywallOverlay_1

components_charts_MarginsChart_0

components_charts_MarginsChart_19

Neurobiological Technologies components_charts_MarginsChart_21

Neurobiological Technologies components_charts_MarginsChart_15Neurobiological Technologies components_charts_MarginsChart_16Neurobiological Technologies components_charts_MarginsChart_17Neurobiological Technologies components_charts_MarginsChart_16
2010e0 %0 %−305,29 %
20090 %13,98 %11,85 %
20080 %−113,12 %−110,58 %
20070 %−88,28 %−79,94 %
20060 %−133,21 %−225,62 %
20050 %−405,68 %−805,71 %
20040 %−86,61 %−64,90 %
20030 %−142,93 %−135,86 %
20020 %0 %0 %
20010 %21,55 %33,26 %
20000 %0 %0 %
19990 %−3 740,00 %−3 690,00 %
19980 %−108,10 %−103,33 %
19970 %0 %0 %
19960 %0 %0 %
19950 %−776,47 %−776,47 %
19940 %0 %0 %
19930 %0 %0 %
19920 %0 %0 %
19910 %0 %0 %
19900 %0 %0 %

components_charts_RevenuePerShareChart_0

components_charts_RevenuePerShareChart_16

Neurobiological Technologies components_charts_RevenuePerShareChart_18

components_charts_RevenuePerShareChart_17Neurobiological Technologies components_charts_RevenuePerShareChart_10Neurobiological Technologies components_charts_RevenuePerShareChart_12Neurobiological Technologies components_charts_RevenuePerShareChart_11
2010e0,59 undefined0 undefined−1,79 undefined
20090,98 undefined0,14 undefined0,12 undefined
20080,76 undefined−0,86 undefined−0,84 undefined
20074,07 undefined−3,60 undefined−3,26 undefined
20063,03 undefined−4,04 undefined−6,84 undefined
20050,82 undefined−3,32 undefined−6,59 undefined
20040,94 undefined−0,82 undefined−0,61 undefined
20030,77 undefined−1,10 undefined−1,05 undefined
20020 undefined−1,85 undefined−1,70 undefined
20011,59 undefined0,34 undefined0,53 undefined
20000 undefined−2,00 undefined−1,90 undefined
19990,09 undefined−3,46 undefined−3,42 undefined
19982,14 undefined−2,32 undefined−2,21 undefined
19970 undefined−8,37 undefined−7,92 undefined
19960 undefined−8,06 undefined−7,34 undefined
19951,21 undefined−9,43 undefined−9,43 undefined
19940 undefined−11,50 undefined−10,79 undefined
19930 undefined−12,50 undefined−11,86 undefined
19920 undefined−5,62 undefined−5,38 undefined
19910 undefined−3,15 undefined−2,95 undefined
19900 undefined−1,69 undefined−1,63 undefined

pages_aktie_[isin]__4

pages_aktie_[isin]__5

pages_aktie_[isin]__7

Neurobiological Technologies components_StockSplitTable__0

components_StockSplitsTable_0

components_PaywallOverlay_0

components_PaywallOverlay_1
pages_aktie_[isin]__2

Neurobiological Technologies components_EarningsSuprises__0

components_EarningsSuprises__1components_EarningsSuprises__2components_EarningsSuprises__3components_EarningsSuprises__4
30.9.2008−0,16 −0,10  (38,73 %)2009 Q1
30.6.2008−0,19 −0,13  (32,92 %)2008 Q4
31.3.2008−0,22 −0,19  (12,36 %)2008 Q3
31.12.2007−0,20 −0,36  (−83,30 %)2008 Q2
30.9.2007−0,92 −0,19  (79,42 %)2008 Q1
30.6.2007−0,98 −6,37  (−552,80 %)2007 Q4
31.3.2007−0,86 −1,05  (−22,55 %)2007 Q3
31.12.2006−0,93 −0,77  (17,04 %)2007 Q2
30.6.20060 −1,12  (0 %)2006 Q4
31.3.2006−0,50 −0,91  (−82,07 %)2006 Q3
1
2
3
4

components_ESGRating_6

components_ESGRating_7

components_PaywallOverlay_0

components_PaywallOverlay_1

pages_aktie_[isin]__9

components_OwnershipTable__4
components_OwnershipTable__0
components_OwnershipTable__1
components_OwnershipTable__2
components_OwnershipTable__3
9,42 % Ancora Advisors, L.L.C.2 544 675031.12.2023
1

Neurobiological Technologies components_CompanyExecutives__0

Mr. Matthew Loar51
Neurobiological Technologies Acting Chief Executive and Financial Officer, Director - components_CompanyExecutives__1 2008
components_CompanyExecutives__2 345 773,00
William Fletcher65
Neurobiological Technologies Director - components_CompanyExecutives__1 2007
components_CompanyExecutives__2 153 975,00
Mr. John Stuppin79
Neurobiological Technologies Director - components_CompanyExecutives__1 1987
1

pages_aktie_[isin]__1

What values and corporate philosophy does Neurobiological Technologies represent?

Neurobiological Technologies Inc represents a commitment to advancing neuroscience research and providing innovative solutions. The company values scientific rigor, collaboration, and the pursuit of excellence in developing groundbreaking therapies. With a focus on neurological disorders, Neurobiological Technologies Inc aims to improve patients' quality of life and address unmet medical needs. By leveraging cutting-edge technology and a dedicated team of experts, the company strives to push the boundaries of scientific knowledge and create value for its stakeholders. Neurobiological Technologies Inc's corporate philosophy centers around delivering transformative solutions that positively impact the lives of individuals affected by neurological conditions.

In which countries and regions is Neurobiological Technologies primarily present?

Neurobiological Technologies Inc is primarily present in the United States.

What significant milestones has the company Neurobiological Technologies achieved?

Neurobiological Technologies Inc has achieved several significant milestones. Firstly, the company successfully developed and received FDA approval for a novel treatment for Parkinson's disease, XERECEPT®. This marked a major breakthrough in managing the symptoms of the disease. Additionally, Neurobiological Technologies Inc has made significant strides in the research and development of innovative neurological therapies. Their commitment to advancing science and improving patient outcomes has positioned them as a leader in the field of neurobiology. As Neurobiological Technologies Inc continues to innovate and collaborate, the company is poised to achieve even more significant milestones in the future.

What is the history and background of the company Neurobiological Technologies?

Neurobiological Technologies Inc. is a biopharmaceutical company specializing in the development of innovative therapies for neurological disorders. Founded in 1982, the company has established itself as a leader in the neurology field. Throughout its history, Neurobiological Technologies Inc. has focused on researching and developing novel treatments for conditions such as Alzheimer's disease and Parkinson's disease. They have made significant contributions to the understanding of neurobiology and have garnered recognition for their pioneering work. By utilizing cutting-edge technology and scientific expertise, Neurobiological Technologies Inc. continues to make strides in improving the lives of patients affected by neurological disorders.

Who are the main competitors of Neurobiological Technologies in the market?

The main competitors of Neurobiological Technologies Inc in the market include companies such as Biogen Inc., Eli Lilly and Company, and Pfizer Inc.

In which industries is Neurobiological Technologies primarily active?

Neurobiological Technologies Inc is primarily active in the pharmaceutical and biotechnology industries.

What is the business model of Neurobiological Technologies?

Neurobiological Technologies Inc (NTI) is a biopharmaceutical company with a focus on the research, development, and commercialization of innovative therapies for neurological diseases. NTI aims to address unmet medical needs in the field of neurology by developing novel treatments and diagnostics. Their business model revolves around conducting research to identify potential drug candidates, conducting preclinical and clinical trials, seeking regulatory approvals, and commercializing their products. By leveraging their expertise in neurobiology, NTI strives to enhance the quality of life for patients suffering from neurological disorders.

pages_aktie_[isin]__11

pages_aktie_[isin]__13

pages_aktie_[isin]__14

pages_aktie_[isin]__16

pages_aktie_[isin]__17

pages_aktie_[isin]__18

pages_aktie_[isin]__20

pages_aktie_[isin]__22

pages_aktie_[isin]__23

pages_aktie_[isin]__25

pages_aktie_[isin]__26

pages_aktie_[isin]__27

pages_aktie_[isin]__29

pages_aktie_[isin]__30

pages_aktie_[isin]__32

pages_aktie_[isin]__34

pages_aktie_[isin]__35

pages_aktie_[isin]__36

pages_aktie_[isin]__37

pages_aktie_[isin]__38

pages_aktie_[isin]__39

pages_aktie_[isin]__40

pages_aktie_[isin]_[key]_index_0

pages_aktie_[isin]_[key]_index_1

pages_aktie_[isin]_[key]_index_2

pages_aktie_[isin]_[key]_index_3

pages_aktie_[isin]_[key]_index_4

pages_aktie_[isin]_[key]_index_5

pages_aktie_[isin]_[key]_index_6

pages_aktie_[isin]_[key]_index_7

pages_aktie_[isin]_[key]_index_8

pages_aktie_[isin]_[key]_index_9

pages_aktie_[isin]_[key]_index_10

pages_aktie_[isin]_[key]_index_14

Wann musste ich die Aktien von Neurobiological Technologies kaufen, um die vorherige Dividende zu erhalten?

pages_aktie_[isin]_[key]_index_15

pages_aktie_[isin]_[key]_index_16

pages_aktie_[isin]_[key]_index_18

pages_aktie_[isin]_[key]_index_19

pages_aktie_[isin]_[key]_index_20

pages_aktie_[isin]_[key]_index_21

pages_aktie_[isin]_[key]_index_22

pages_aktie_[isin]__10

components_SimilarSitesList_0

components_GenericText_0

components_GenericText_1

components_GenericText_2

components_GenericText_3

components_GenericText_4

components_GenericText_5

components_GenericText_6

components_GenericText_7

components_GenericText_8

components_GenericText_9

components_GenericText_10

components_GenericText_11

components_GenericText_12

components_GenericText_13

components_GenericText_14

components_GenericText_15

components_GenericText_16

components_GenericText_17

components_GenericText_18

components_GenericText_19

components_GenericText_20

components_GenericText_21

components_GenericText_22

components_GenericText_23

components_GenericText_24

components_GenericText_25

components_GenericText_26

components_GenericText_27

components_GenericText_28

components_GenericText_29

components_GenericText_30

components_GenericText_31

components_GenericText_32

components_GenericText_33

components_GenericText_34

components_GenericText_35

components_GenericText_36

components_GenericText_37

components_GenericText_38

components_GenericText_39

components_GenericText_40

components_GenericText_41

components_GenericText_42

components_GenericText_43

components_GenericText_44

components_GenericText_45

components_GenericText_46

components_GenericText_47

components_GenericText_48

components_GenericText_49

components_GenericText_50

components_GenericText_51

components_GenericText_52

components_GenericText_53

components_GenericText_54

components_GenericText_55

components_GenericText_56

components_GenericText_57

components_GenericText_58

components_GenericText_59

components_GenericText_60

components_GenericText_61

components_GenericText_62

components_GenericText_63

components_GenericText_64

components_GenericText_65

components_GenericText_66

components_GenericText_67

components_GenericText_68

components_GenericText_69

components_GenericText_70

components_GenericText_71

components_GenericText_72

components_GenericText_73

components_GenericText_74

components_GenericText_75

components_GenericText_76

components_GenericText_77

components_GenericText_78

components_GenericText_79

components_GenericText_80

components_GenericText_81

components_GenericText_82

components_GenericText_83

components_GenericText_84

components_GenericText_85

components_GenericText_86

components_GenericText_87

components_GenericText_88

components_GenericText_89

components_GenericText_90

components_GenericText_91

components_GenericText_92

components_GenericText_93

components_GenericText_94

components_GenericText_95

components_GenericText_96

components_GenericText_97

components_GenericText_98

components_GenericText_99

components_GenericText_100

components_GenericText_101

components_GenericText_102

components_GenericText_103

components_GenericText_104

components_GenericText_105

components_GenericText_106

components_GenericText_107

components_GenericText_108

components_GenericText_109

components_GenericText_110

components_GenericText_111

components_GenericText_112

components_GenericText_113

components_GenericText_114

components_GenericText_115

components_GenericText_116

components_GenericText_117

components_GenericText_118

components_GenericText_119

components_GenericText_120

components_GenericText_121

components_GenericText_122

components_GenericText_123

components_GenericText_124

components_GenericText_125

components_GenericText_126

components_GenericText_127

components_GenericText_128

components_GenericText_129

components_GenericText_130

components_GenericText_131

components_GenericText_132

components_GenericText_133

components_GenericText_134

components_GenericText_135

components_GenericText_136

components_GenericText_137

  • components_GenericText_138components_GenericText_139
  • components_GenericText_140components_GenericText_141
  • components_GenericText_142components_GenericText_143
  • components_GenericText_144components_GenericText_145
  • components_GenericText_146components_GenericText_147
  • components_GenericText_148components_GenericText_149
  • components_GenericText_150components_GenericText_151
  • components_GenericText_152components_GenericText_153
  • components_GenericText_154components_GenericText_155

components_GenericText_156

components_GenericText_157

components_GenericText_158

components_GenericText_159

components_GenericText_160

components_GenericText_161

components_GenericText_162

components_GenericText_163

  • components_GenericText_164components_GenericText_165
  • components_GenericText_166components_GenericText_167
  • components_GenericText_168components_GenericText_169
  • components_GenericText_170components_GenericText_171
  • components_GenericText_172components_GenericText_173
  • components_GenericText_174components_GenericText_175

components_GenericText_176

components_GenericText_177

components_GenericText_178

components_GenericText_179

components_GenericText_180

components_GenericText_181

components_GenericText_182

components_GenericText_183

components_GenericText_184

components_GenericText_185

components_GenericText_186

components_GenericText_187

components_GenericText_188

components_GenericText_189

components_GenericText_190

components_GenericText_191

components_GenericText_192

components_GenericText_193

components_GenericText_194

components_GenericText_195

components_GenericText_196

components_GenericText_197

components_GenericText_198

components_GenericText_199

components_GenericText_200

components_GenericText_201

components_GenericText_202

components_GenericText_203

components_GenericText_205components_GenericText_204

components_GenericText_207components_GenericText_206

components_GenericText_208components_GenericText_209

components_GenericText_210

components_GenericText_211components_GenericText_212

components_GenericText_213components_GenericText_214

components_GenericText_215components_GenericText_216

components_GenericText_217

components_GenericText_219components_GenericText_218

components_GenericText_220components_GenericText_221

components_GenericText_222components_GenericText_223

components_GenericText_224

components_GenericText_225

components_GenericText_226

components_GenericText_227

components_GenericText_228

components_GenericText_229

components_GenericText_230

components_GenericText_231

components_GenericText_232

components_GenericText_233

components_GenericText_234

components_GenericText_235

components_GenericText_236

components_GenericText_237

components_GenericText_238

components_GenericText_239

components_GenericText_240

components_GenericText_241

components_GenericText_242

components_GenericText_243

components_GenericText_244

components_GenericText_245

components_GenericText_246

components_GenericText_247

components_GenericText_248

components_GenericText_249

components_GenericText_250

components_GenericText_251

components_GenericText_252

components_GenericText_253

components_GenericText_254

components_GenericText_255

components_GenericText_256

components_GenericText_257

components_GenericText_258

components_GenericText_259

components_GenericText_260

components_GenericText_261

components_GenericText_262

components_GenericText_263

components_GenericText_264

components_GenericText_265

components_GenericText_266

components_GenericText_267

components_GenericText_268

components_GenericText_269

components_GenericText_270

components_GenericText_271

components_GenericText_272

components_GenericText_273 components_GenericText_274:

  • components_GenericText_275components_GenericText_276
  • components_GenericText_277components_GenericText_278
  • components_GenericText_279components_GenericText_280
  • components_GenericText_281components_GenericText_282
  • components_GenericText_283components_GenericText_284
  • components_GenericText_285components_GenericText_286
  • components_GenericText_287components_GenericText_288

components_GenericText_289

components_GenericText_290 components_GenericText_291:

  • components_GenericText_292components_GenericText_293
  • components_GenericText_294components_GenericText_295
  • components_GenericText_296components_GenericText_297
  • components_GenericText_298components_GenericText_299

components_GenericText_300

components_GenericText_301